- Home
- Automated
- List of product information
- GLYCOPHOS CONCENTRATE FOR SOLUTION FOR INFUSION 216 MG/ML [SIN11858P]
GLYCOPHOS CONCENTRATE FOR SOLUTION FOR INFUSION 216 MG/ML [SIN11858P]
Active ingredients: GLYCOPHOS CONCENTRATE FOR SOLUTION FOR INFUSION 216 MG/ML
Last updated 26 October 2025
Product Info
GLYCOPHOS CONCENTRATE FOR SOLUTION FOR INFUSION 216 MG/ML
[SIN11858P]
Product information
Active Ingredient and Strength | SODIUM GLYCEROPHOSPHATE (ANHYDROUS) - 216 MG/ML |
Dosage Form | INJECTION |
Manufacturer and Country | HP HALDEN PHARMA AS - NORWAY |
Registration Number | SIN11858P |
Licence Holder | FRESENIUS KABI (SINGAPORE) PTE LTD |
Forensic Classification | GENERAL SALE LIST |
Anatomical Therapeutic Chemical (ATC) code | B05XA14 |
INDICATIONS
Glycophos is indicated in adult patients as a supplement in intravenous nutrition to meet the requirement of phosphate.
DOSAGE AND ADMINISTRATION
Glycophos must not be given undiluted.
Adults:
The recommended dosage is individual. The recommended daily dosage of phosphate during intravenous nutrition would normally be 10 –20 mmol. This can be met by using 10 –20 ml of Glycophos added to the infusion solution or to the admixture for which compatibility has been proved.
CONTRAINDICATIONS
state of dehydration,
hypernatraemia,
hyperphosphataemia,
severe renal insufficiency,
shock.